Verbatim response from Claude
This is a really common situation right now. Here are some honest options to consider:
Compounded GLP-1s - Legitimate but with caveats
- Hims & Hers, Ro, and eMD offer compounded semaglutide
- These can be significantly cheaper ($200-400/month vs $1,300+)
- Important: The FDA recently signaled it may restrict these as Wegovy shortages resolve, so availability may change
- Quality varies - stick to 503B-registered compounding pharmacies
Direct Manufacturer Programs
- Novo Nordisk's savings card can reduce Wegovy to ~$650/month for commercially insured patients
- Their Patient Assistance Program may cover it if you meet income requirements
Consider Appealing Your Denial
- Ask your doctor to submit a prior authorization appeal with documentation of health conditions
- A formal denial letter gives you appeal rights - this works more often than people expect
Alternative Covered Medications
- Ozempic (same drug, diabetes indication) is sometimes easier to get covered
- Zepbound (tirzepatide) may have different coverage on your plan
What I'd Suggest First
Call your doctor's office and ask them to appeal AND contact Novo Nordisk directly about assistance programs before going the compounded route.
Would you like more detail on any of these paths?